SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Rebecca Johnson,1 Nirupama Sabnis,2 Xiangle Sun,1 Ruhani Ahluwalia,3 Andras G Lacko2,4 1Institute of Molecular Medicine, 2Institute for Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center, 3Harmony School of Innovation, 4Department of Pediatrics, University of Nort...

Full description

Bibliographic Details
Main Authors:	Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-06-01
Series:	Breast Cancer : Targets and Therapy
Subjects:	breast cancer TNBC rHDL nanoparticles SR-B1 receptors targeted drug delivery lapatinib valrubicin
Online Access:	https://www.dovepress.com/sr-b1-targeted-nanodelivery-of-anti-cancer-agents-a-promising-new-appr-peer-reviewed-article-BCTT

Similar Items

Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
by: Sabnis S, et al.
Published: (2017-02-01)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
by: Sangram Raut, et al.
Published: (2018-10-01)

Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus
by: Brian G. Drew, et al.
Published: (2011-03-01)

Pre-clinical evaluation of rHDL encapsulated retinoids for the treatment of Neuroblastoma
by: Nirupama eSabnis, et al.
Published: (2013-03-01)

DNA-binding studies of valrubicin as a chemotherapy drug using spectroscopy and electrochemical techniques
by: Reza Hajian, et al.
Published: (2017-06-01)

Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
by: Shifa Jebari-Benslaiman, et al.
Published: (2020-09-01)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
by: Karin Kornmueller, et al.
Published: (2019-08-01)

Interaction of Recombinant Paraoxonase-1 with Reconstituted High-Density Lipoproteins
by: Baldauff, Rachel Michelle
Published: (2011)

Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mices⃞
by: Yunlong Wang, et al.
Published: (2008-08-01)

New Approaches for the Treatment of Triple Negative Breast Cancer
by: Sulaiman, Andrew
Published: (2019)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed Asadolah Mousavi, et al.
Published: (2013-03-01)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed AsadoLah Mousavi, et al.
Published: (2013-01-01)

Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo
by: Louise Rottboell, et al.
Published: (2015-12-01)

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
by: Ranjita Misra, et al.
Published: (2021-05-01)

SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer
by: Jorge L. Gutierrez-Pajares, et al.
Published: (2016-10-01)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
by: Shoghag Panjarian, et al.
Published: (2021-06-01)

Therapeutic landscape in mutational triple negative breast cancer
by: Yaqin Shi, et al.
Published: (2018-07-01)

Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
by: Linda K Mooberry, et al.
Published: (2016-12-01)

Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
by: Anderson Vulczak, et al.
Published: (2020-03-01)

Novel therapeutic strategies for patients with triple-negative breast cancer
by: Zhang J, et al.
Published: (2016-10-01)

Novel Aminoglycoside Polymers and Combination Treatments in Triple Negative Breast Cancer Studies
Published: (2018)

Effect of Ect2 Expression on the Growth of Triple-Negative Breast Cancer Cells with Paclitaxel Intervention
by: Wang H, et al.
Published: (2020-12-01)

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
by: Dong Wang, et al.
Published: (2017-03-01)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)

Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms
by: Shan-Ju Yeh, et al.
Published: (2021-03-01)

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
by: Parijat Senapati, et al.
Published: (2019-07-01)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
by: Rui Zhou, et al.
Published: (2020-07-01)

Prognostic Value of Androgen Receptor in Triple Negative Breast Cancer of Iranian Patients in Yazd Region
by: Fatemeh Alsadat Nobakht, et al.
Published: (2020-11-01)

Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy
by: Zhang M, et al.
Published: (2017-01-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
by: Ye Han, et al.
Published: (2020-11-01)

Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
by: Patrizia Mancini, et al.
Published: (2014-10-01)

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
by: Li MX, et al.
Published: (2018-07-01)

Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
by: Ren K, et al.
Published: (2018-10-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
by: Pere Llinàs-Arias, et al.
Published: (2021-08-01)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
by: Assunta Sellitto, et al.
Published: (2020-06-01)

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
by: Liao Y, et al.
Published: (2018-09-01)

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
by: Shanshan Wang, et al.
Published: (2021-01-01)